Gentium (GENT) Creates Commerical Ops Subsidiary

Gentium S.p.A. (Nasdaq: GENT) has established a wholly owned subsidiary Gentium GmbH, located in Zug, Switzerland, as the headquarters for its commercial operations as well as the appointment of key members of the commercial leadership team who will be responsible for the global commercialization of Defibrotide once marketing approval for Defibrotide is obtained. The team plans to provide a direct sales force in Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland and the United Kingdom and to manage sales through several distributor partners for the rest of the world. Prior to marketing approval for Defibrotide, the team will oversee the named-patient program.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• McCormick board member to resign after CFO appointment at Best Buy
• Pinterest CFO resigns, interim replacement named
• Volitionrx Limited (VNRX) files for 10M share offering by selling stockholders